Literature DB >> 1431426

Complement profile in primary biliary cirrhosis.

M Schlesinger1, C Benbassat, Y Shoenfeld.   

Abstract

PBC is a chronic progressive liver disease of unknown etiology. Several abnormalities found in PBC support the hypothesis that it may be considered an autoimmune disease. Despite the complex and interesting relationship that exists between autoimmune disorders and the complement system, very few reports on the level of the serum complement component in PBC have been published, and most of these comprised only a few patients or analyzed only a scant number of the complement components. In the present study, sera of 73 PBC patients were analyzed for the levels of 10 complement components. It was found that the levels of most of the serum complement components, including C1q, C2, C3, C5, C7, properdin and factor B were significantly elevated in patients with PBC in comparison to healthy controls. The level of C4 was slightly lower than that of the normal controls (p = 0.019), while the levels of C6 and C8 were within the normal range. The number of PBC patients with serum levels of C4 and C6 < 60% of normal pooled serum was higher than in the respective control groups (6/69 compared with 0/26 and 4/71 compared with 0/27, respectively). However, the difference was not statistically significant. Thus, our study shows alterations in the levels of most complement components in PBC, the reasons for which are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431426     DOI: 10.1007/bf02918614

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  21 in total

1.  Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis.

Authors:  A Ruffatti; P Arslan; A Floreani; G De Silvestro; A Calligaro; R Naccarato; S Todesco
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

2.  Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis.

Authors:  B J Potter; E Elias; E A Jones
Journal:  J Lab Clin Med       Date:  1976-09

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Component deficiencies. 2. The fourth component.

Authors:  G Hauptmann; J Goetz; B Uring-Lambert; E Grosshans
Journal:  Prog Allergy       Date:  1986

5.  Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years.

Authors:  R C Gupta; E R Dickson; F C McDuffie; A H Baggenstoss
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

6.  Complement components and activation in primary biliary cirrhosis.

Authors:  S Lindgren; A B Laurell; S Eriksson
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

7.  Increased incidence of hypothyroidism in primary biliary cirrhosis.

Authors:  G H Elta; R A Sepersky; M J Goldberg; C M Connors; K B Miller; M M Kaplan
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

8.  Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.

Authors:  B J Potter; E Elias; H C Thomas; S Sherlock
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

9.  Complement levels in patients with hepatic dysfunction.

Authors:  R T Ellison; C R Horsburgh; J Curd
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

10.  Circulating immune complexes in primary biliary cirrhosis: interactions with lymphoid cells.

Authors:  J L Dienstag; A M Savarese; R B Cohen; A K Bhan
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

View more
  6 in total

1.  The complement system and systemic sclerosis.

Authors:  C Benbassat; M Schlesinger; C Luderschmidt; G Valentini; G Tirri; Y Shoenfeld
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

2.  Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 3.  Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis.

Authors:  Hussain Syed; Tara Penner; Andrew L Mason
Journal:  Viruses       Date:  2022-08-31       Impact factor: 5.818

4.  TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis.

Authors:  Joanna Raszeja-Wyszomirska; Ewa Wunsch; Agnieszka Kempinska-Podhorodecka; Daniel S Smyk; Dimitrios P Bogdanos; Malgorzata Milkiewicz; Piotr Milkiewicz
Journal:  Clin Dev Immunol       Date:  2013-04-28

Review 5.  Infectome: a platform to trace infectious triggers of autoimmunity.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Shideh Pouria; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2012-12-22       Impact factor: 9.754

Review 6.  Tracing environmental markers of autoimmunity: introducing the infectome.

Authors:  Dimitrios P Bogdanos; Daniel S Smyk; Pietro Invernizzi; Eirini I Rigopoulou; Miri Blank; Lazaros Sakkas; Shideh Pouria; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.